Records whose title is actually about this topic. Use a country filter if the list is still too broad.
Records
Bill· SS. 2081 (116th)referred
United States · United States Congress · 10 July 2019
Stop Drug Companies from Overcharging Seniors in Medicare Part B Act of 2019 This bill requires manufacturers of covered drugs under Medicare medical services to issue rebates to the Centers for Medicare & Medicaid Services. Rebates are calculated based on the number of units sold and the amount by which the manufacturer price exceeds inflation. The bill's requirements do not apply to drugs that cost less than $100 annually per user in 2020 (and as adjusted for inflation annually thereafter) or to drugs on a specified drug shortage list. The bill also eliminates cost-sharing for such drugs for beneficiaries whose out-of-pocket costs meet or exceed a specified threshold.
Bill· SS. 2080 (116th)referred
United States · United States Congress · 10 July 2019
Palliative Care and Hospice Education and Training Act This bill requires the Department of Health and Human Services (HHS) to take a series of actions relating to palliative-care training. Specifically, HHS must provide support for Palliative Care and Hospice Education Centers. The centers must improve the training of health professionals in palliative care and establish traineeships for individuals preparing for advanced-education nursing degrees, social-work degrees, or advanced degrees in physician-assistant studies in palliative care. HHS may provide support to medical schools, teaching hospitals, and graduate medical-education programs for training physicians who plan to teach palliative medicine. HHS must (1) provide Palliative Medicine and Hospice Academic Career Awards to individuals to promote their career development, (2) support entities that operate a Palliative Care and Hospice Education Center, (3) support individuals in specified fields who are pursuing an advanced degree in palliative care or related fields, and (4) award grants to nursing programs to train individuals in providing palliative care. The Agency for Healthcare Research and Quality must provide for a national education and awareness campaign to inform patients, families, and health professionals about the benefits of palliative care. The National Institutes of Health must expand national research programs in palliative care.
Bill· SS. 2074 (116th)referred
United States · United States Congress · 10 July 2019
Mainstreaming Addiction Treatment Act of 2019 This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration (DEA) to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment). Further, a community health aide or community health practitioner may dispense certain narcotic drugs for maintenance or detoxification treatment without registering with the DEA if the drug is prescribed by a health care practitioner through telemedicine. It preempts state laws related to licensure for this activity. The bill also directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.
Bill· SS. 2067 (116th)referred
United States · United States Congress · 10 July 2019
Affordable Health Care for Children with Disabilities Act This bill establishes an enhanced Federal Medical Assistance Percentage (i.e., federal matching rate) for services provided under state Medicaid programs to individuals 18 years of age or younger who have disabilities and whose income and resources do not exceed certain thresholds, regardless of parental income and resources.
Bill· HRH.R. 3636 (116th)open
United States · United States Congress · 9 July 2019
Caring For Our Women Veterans Act This bill establishes various reporting requirements for the Department of Veterans Affairs (VA) related to women veterans and health care. Specifically, the bill requires the VA to submit reports on (1) women veterans' use of health care from the VA; (2) use by the VA of general primary care clinics, separate but shared spaces, and women's health centers as models of providing health care to women veterans; and (3) the staffing of the VA related to the treatment of women.
Bill· HRH.R. 3631 (116th)open
United States · United States Congress · 9 July 2019
Territories Health Care Improvement Act This bill makes a series of changes relating to Medicaid funding for U.S. territories, including by (1) establishing a specific funding cap through FY2023 for Puerto Rico and through FY2025 for the other U.S. territories, (2) establishing program integrity measures and reporting requirements relating to the use of funds, and (3) increasing the applicable Federal Medical Assistance Percentage (i.e., the federal matching rate).
Bill· HRH.R. 3630 (116th)open
United States · United States Congress · 9 July 2019
No Surprises Act This bill expands restrictions on charging health care plan holders out-of-network rates for certain services. First, the bill requires insurers offering plans that cover emergency services to bill plan holders no more than the median in-network rate for a particular emergency service, even if the service provider is out of network. The bill further prohibits insurers from billing plan holders more than the median in-network rate for nonemergency services provided by out-of-network providers at in-network facilities. Out-of-network providers may not bill plan holders for the difference between the in-network and out-of-network rates for emergency services. The bill further prohibits out-of-network providers from billing plan holders for the difference in rates for nonemergency services provided at an in-network facility unless the provider complies with specified notice and consent requirements. Even when complying with these requirements, an out-of-network provider may not charge plan holders for the difference in rates for such nonemergency services if the provider is based at the in-network facility and is the only provider available to deliver the particular treatment or service at the facility. The Department of Health and Human Services must provide grants to states to establish or maintain All Payer Claims Databases, which publish claims and payment information from insurers. The bill also requires insurers to publish provider directories and requires the Government Accountability Office and the Department of Labor to report on certain issues related to the commercial health care market.
Bill· HRH.R. 3656 (116th)referred
United States · United States Congress · 9 July 2019
Accessible Care by Curbing Excessive lawSuitS Act of 2019 or ACCESS Act of 2019 This bill establishes rules for health care lawsuits where some amount of coverage or care was provided or paid for by a federal program, regardless of the number of other parties to the claim. The bill sets a three-year maximum statute of limitations from the date of the injury, subject to specific exceptions. Further, noneconomic damages (e.g., damages for pain and suffering) are limited to a maximum of $250,000. The bill permits courts to supervise and limit contingent fees paid to attorneys and sets a maximum contingent fee percentage based on a downward sliding scale as a damages increase. The bill permits either party to introduce evidence of collateral source benefits (e.g., workers’ compensation programs, accident insurance coverage, or other future benefit). Statements by a health care provider expressing fault, sympathy, or apology are, however, inadmissible as evidence of liability. Additionally, a plaintiff must give 90 days’ notice to the health care provider before filing a lawsuit. When filing a health care lawsuit, plaintiffs also must simultaneously submit an affidavit in support of the claim from a health care professional who meets the standards for an expert witness that are provided in the bill. This bill generally does not preempt state laws that impose additional limits on health care liability claims.
Bill· HRH.R. 3654 (116th)referred
United States · United States Congress · 9 July 2019
Chiropractic Medicare Coverage Modernization Act of 2019 This bill expands Medicare coverage of chiropractic services to include all services provided by chiropractors, rather than only subluxation corrections through manual manipulation of the spine.
Bill· HRH.R. 3649 (116th)referred
United States · United States Congress · 9 July 2019
Treatment Family Care Services Act This bill requires the Department of Health and Human Services (HHS) to issue guidance outlining opportunities for states to fund treatment family care services through Medicaid, the Payments for Foster Care and Permanency program, or other HHS programs. Treatment family care services are structured, daily emotional and behavioral services and interventions provided in a home-based setting for children less than 21 years old. Additionally, HHS must develop and issue guidance about best practices for states to establish treatment family care services programs.
Bill· HRH.R. 3644 (116th)referred
United States · United States Congress · 9 July 2019
Independence at Home Demonstration Act of 2019 This bill extends the Independence at Home Demonstration Program for an additional three years. The program provides Medicare beneficiaries who have multiple chronic conditions with home-based primary care.
Bill· HRH.R. 3637 (116th)referred
United States · United States Congress · 9 July 2019
Allied Health Workforce Diversity Act of 2019 This bill allows the Department of Health and Human Services to provide grants to accredited education programs to increase diversity in the physical-therapy, occupational-therapy, audiology, and speech-language pathology professions. Grants may be used to provide scholarships or to support recruitment and retention of students from underrepresented groups.
Bill· HRH.R. 3634 (116th)referred
United States · United States Congress · 9 July 2019
Medicaid and CHIP Territory Transparency and Information Act This bill requires the Centers for Medicare & Medicaid Services to publish on its website, and periodically update, specified information related to federal expenditures under Medicaid and the Children's Health Insurance Program (CHIP) in each of the U.S. territories.
Resolution· HRESH.Res. 480 (116th)referred
United States · United States Congress · 9 July 2019
This resolution acknowledges the disparities in diagnosing and treating mental health issues among youth from communities of color and expresses support for researching best practices, increasing access to care, funding education and training programs, and increasing diversity among mental health professionals.
Bill· SS. 2063 (116th)referred
United States · United States Congress · 9 July 2019
Organ Procurement Optimization Act of 2019 This bill revises the procedures that organ procurement agencies must follow for hospitals to receive reimbursement through Medicare or Medicaid for payments made to such agencies. In addition to the existing requirements, the Centers for Medicare & Medicaid Services may reimburse a hospital only if the organ procurement agency relies on standardized, objective, verifiable performance metrics, which must be established through administrative rulemaking within one year of the bill's enactment.
Resolution· SRESS.Res. 273 (116th)referred
United States · United States Congress · 9 July 2019
This resolution expresses the sense of the Senate that everyone in the United States has certain rights with respect to health care, including affordable coverage, access to care, transparency and privacy, protection from discrimination, and culturally appropriate care.
Bill· HRH.R. 3613 (116th)referred
United States · United States Congress · 2 July 2019
State Accountability, Flexibility, and Equity for Hospitals Act of 2019 or the SAFE Hospitals Act of 2019 This bill alters Medicaid requirements relating to payment for inpatient hospital services that are provided by disproportionate share hospitals (DSHs). (DSHs are hospitals that receive additional payment under Medicaid for treating a large share of low-income patients.) Among other changes, the bill requires state Medicaid programs to adopt a payment methodology that meets certain criteria, including by prioritizing payments based on the DSH tier for which the hospital qualifies; tiers are determined based on factors such as the hospital's Medicaid inpatient utilization rate. The bill also incorporates state poverty ratios (i.e., the number of qualifying low-income individuals in a state compared to all states) into the formula for determining state DSH allotments under Medicaid. The bill phases in application of the revised formula over the course of 10 to 15 years.
Bill· HRH.R. 3594 (116th)referred
United States · United States Congress · 28 June 2019
Healthcare Freedom Act of 2019 This bill expands the availability of health savings accounts. It renames such accounts as "health freedom accounts" and allows all individuals to receive increased tax deductions for contributions to such accounts. The term "qualified medical expenses" is expanded to include costs associated with direct primary care, health care sharing ministries, and medical cost sharing organizations. The bill also excludes employer contributions to health freedom accounts from employee gross income for income tax purposes.
Bill· SS. 2051 (116th)referred
United States · United States Congress · 28 June 2019
Strengthening Average Sales Price Reporting Act of 2019 This bill requires certain manufacturers of drugs that are covered under Medicare medical services to report pricing information to the Centers for Medicare & Medicaid Services. Specifically, manufacturers of such drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.
Bill· HRH.R. 3539 (116th)referred
United States · United States Congress · 27 June 2019
Behavioral Intervention Guidelines Act of 2019 This bill requires the Substance Abuse and Mental Health Services Administration (SAMHSA) to develop best practices for schools to establish behavioral intervention teams (i.e., experts who are responsible for identifying individuals of concern and addressing associated behavioral health issues so as to prevent harm to the individual or others). SAMHSA must also develop a list of providers with threat-assessment training to help school personnel implement the best practices.
Bill· HRH.R. 3530 (116th)referred
United States · United States Congress · 27 June 2019
Improving Confidence in Veterans' Care Act This bill addresses licensure and employment requirements for medical providers of the Department of Veterans Affairs (VA). Specifically, for VA medical provider positions that require a person to prescribe controlled substances, the bill prohibits a person from being employed if their Drug Enforcement Administration (DEA) registration has been terminated, revoked, or surrendered, and they have not received a waiver from the DEA. The bill also requires the VA to take prompt adverse personnel actions against a medical provider employee (1) who is not licensed, registered, certified, or in receipt of a DEA waiver; or (2) who does not promptly notify the VA of any suspension in such license, registration, or certification. Additionally, the VA must conduct biennial audits of medical provider employees to ensure they are licensed, registered, or certified as required. The VA shall ensure that the hiring process includes a request for licensure status and a verification of licensure status before an individual begins employment. Finally, the VA shall provide annual training on these licensure and employment requirements to directors of the Veterans Integrated Service Networks, as well as chiefs of staff and directors of VA health care facilities.
Bill· HRH.R. 3563 (116th)referred
United States · United States Congress · 27 June 2019
Stop Shackling and Detaining Pregnant Women Act This bill prohibits the Department of Homeland Security (DHS) from detaining a woman during pregnancy or postpartum recovery and must immediately release any detainee found to be pregnant, unless such woman presents an immediate and serious threat of hurting herself or others. A DHS detention facility may not use a restraint on a detainee who is known to be pregnant, including during labor, transport to a medical facility or birthing center, and delivery, or during postpartum recovery, except for medical or safety purposes. The bill requires DHS to use the least restrictive restraint necessary and prohibits certain specified restraint types, including four-point restraints and binding a detainee's hands behind her back. The bill prohibits DHS detention officers from being present during a pelvic exam of a detainee, labor, delivery, or treatment relating to a pregnancy, unless specifically requested by medical personnel. If a detention officer is requested by medical personnel, such officer shall be female, if practicable, and remain at a reasonable distance from the detainee. The bill requires that a pregnant detainee shall have access to health care services, including comprehensive services relating to reproductive health care and pregnancy.
Bill· HRH.R. 3527 (116th)referred
United States · United States Congress · 27 June 2019
POW Priority Care Act of 2019 This bill increases the priority status of former prisoners of war in the Department of Veterans Affairs health care system to the highest priority for hospital care and medical services.
Bill· HRH.R. 3592 (116th)referred
United States · United States Congress · 27 June 2019
PATH Fairness Act of 2019 This bill reauthorizes through FY2024 and revises the Projects for Assistance in Transition from Homelessness. The program provides services to individuals who (1) are suffering from serious mental illness, or are suffering from serious mental illness and from substance abuse; and (2) are homeless or at imminent risk of becoming homeless. The minimum allotment of program funding for each state and territory is increased on the condition that appropriations are sufficient to provide the minimum allotment to all states and territories.
Bill· HRH.R. 3584 (116th)referred
United States · United States Congress · 27 June 2019
Laboratory Access for Beneficiaries Act or the LAB Act This bill revises the periods during which laboratories must report clinical diagnostic test information to the Centers for Medicare & Medicaid Services (CMS) for purposes of determining Medicare payment rates. The CMS must also contract with the National Academies of Sciences, Engineering, and Medicine to evaluate the methodology used to determine a specified laboratory fee schedule.
Bill· HRH.R. 3580 (116th)referred
United States · United States Congress · 27 June 2019
Ensuring Accurate and Complete Abortion Data Reporting Act of 2019 This bill requires states, as a condition of federal payment under Medicaid for family planning services, to report certain abortion data to the Centers for Disease Control and Prevention (CDC). (Currently, reporting is voluntary.) The CDC must develop standardized questions for states with respect to specified variables (e.g., maternal demographics and methods of abortion).
Bill· HRH.R. 3573 (116th)referred
United States · United States Congress · 27 June 2019
Cerebral Cavernous Malformations Clinical Awareness, Research, and Education Act of 2019 or the CCM-CARE Act This bill requires the National Institutes of Health (NIH) and other agencies to expand and coordinate their efforts to research cerebral cavernous malformation. (Cerebral cavernous malformation is a condition in which blood vessels in the brain and spinal cord become enlarged, which can lead to seizures, paralysis, hearing or vision loss, and bleeding in the brain.) The NIH must (1) award grants for medical, clinical, and pharmacological research; (2) award grants to support a network of clinical research centers intended to develop a cure for the condition; and (3) convene a Cerebral Cavernous Malformations Research Consortium to develop programs for clinicians, scientists, and patients. The Centers for Disease Control and Prevention must award grants to research entities for collecting and reporting data about cerebral cavernous malformation. The Food and Drug Administration must accelerate the clinical trial process for cerebral cavernous malformation by supporting (1) appropriate laboratory indicators of the condition, (2) the qualification of clinical outcome measures related to quality of life, (3) investigational drug applications, and (4) expedited peer-review pathways.
Bill· HRH.R. 3568 (116th)referred
United States · United States Congress · 27 June 2019
Tick Identification Pilot Program Act of 2019 This bill authorizes the Centers for Disease Control and Prevention to award grants to states to implement tick-identification programs, which must allow individuals to electronically report tick incidents and receive feedback from experts as to the appropriate follow-up action.
Bill· HRH.R. 3558 (116th)referred
United States · United States Congress · 27 June 2019
21st Century Hospitals Act This bill requires the Department of Health and Human Services (HHS) to study the infrastructure of hospitals nationwide. HHS must study the (1) barriers to infrastructure funding at hospitals in underserved communities; and (2) condition of information technology in hospitals, among other parameters.
Bill· HRH.R. 3534 (116th)referred
United States · United States Congress · 27 June 2019
USPSTF Transparency and Accountability Act of 2019 This bill imposes additional requirements on, and otherwise revises provisions related to, the U.S. Preventive Services Task Force. The task force must (1) develop and publish research plans that include specified components to guide its review of scientific evidence relating to the effectiveness of preventive services; (2) publish in the Federal Register a request for comments on research plans, evidence reports, and recommendations; and (3) convene a preventive services stakeholders board to provide feedback and recommend preventive services and scientific evidence for the task force to review. The bill also provides statutory authority for the task force's system for grading preventive care (Grades A, B, C, and D and a Grade I for insufficient information). In addition, the bill revises the authority of the Centers for Medicare & Medicaid Services (CMS) to modify Medicare coverage of certain preventive services when the modification is based on a task force recommendation. Specifically, the CMS may modify coverage based on a task force grade or recommendation only if it was developed or updated in accordance with this bill and if the CMS agrees with it after consulting with other agencies and stakeholder groups. Certain Medicare quality measures related to a recommendation of the task force may similarly only be applied under these circumstances.
Resolution· HRESH.Res. 470 (116th)referred
United States · United States Congress · 27 June 2019
This resolution expresses support for the designation of National Health Literacy Day.
Resolution· HRESH.Res. 467 (116th)referred
United States · United States Congress · 27 June 2019
This resolution reaffirms the important role of local frontline health workers in promoting global health, specifically in the aftermath of humanitarian and public health crises. The resolution calls on relevant federal agencies to implement certain measures in order to strengthen the frontline health workforce.
Law· SS. 2047 (116th)enacted
United States · United States Congress · 27 June 2019
This bill (1) temporarily extends the Medicaid demonstration program for certified community behavioral health clinics, and (2) reduces funding available to the Medicaid Improvement Fund beginning in FY2021.
Bill· SS. 2046 (116th)referred
United States · United States Congress · 27 June 2019
Protect Health Care for Retired Public Safety Officers Act of 2019 This bill directs the Federal Emergency Management Agency (FEMA), under the State Homeland Security Grant Program, to require each state to include in its grant application a certification for the protection of health care benefits for retired public safety officers. A public safety officer is a law enforcement officer, firefighter, or an emergency medical services provider whose conditions of employment are determined by a collective bargaining agreement. Such certification must provide that the state will not (1) unilaterally modify or eliminate health care benefits for a public safety officer retiree, or (2) allocate grant funds to a local government or Indian tribe that has not certified to the state that such benefits will not be unilaterally modified or eliminated.
Bill· SS. 2020 (116th)referred
United States · United States Congress · 27 June 2019
Screenings for Eye Evaluation, Monitoring, Observation, Review, and Examination Act or the SEE MORE Act This bill exempts telehealth services involving remote imaging for chronic eye disease from specified requirements, such as geographic restrictions, under Medicare.
Bill· SS. 2010 (116th)referred
United States · United States Congress · 27 June 2019
Cerebral Cavernous Malformations Clinical Awareness, Research, and Education Act of 2019 or the CCM-CARE Act This bill requires the National Institutes of Health (NIH) and other agencies to expand and coordinate their efforts to research cerebral cavernous malformation. (Cerebral cavernous malformation is a condition in which blood vessels in the brain and spinal cord become enlarged, which can lead to seizures, paralysis, hearing or vision loss, and bleeding in the brain.) The NIH must (1) award grants for medical, clinical, and pharmacological research; (2) award grants to support a network of clinical research centers intended to develop a cure for the condition; and (3) convene a Cerebral Cavernous Malformations Research Consortium to develop programs for clinicians, scientists, and patients. The Centers for Disease Control and Prevention must award grants to research entities for collecting and reporting data about cerebral cavernous malformation. The Food and Drug Administration must accelerate the clinical trial process for cerebral cavernous malformation by supporting (1) appropriate laboratory indicators of the condition, (2) the qualification of clinical outcome measures related to quality of life, (3) investigational drug applications, and (4) expedited peer-review pathways.
Bill· SS. 2004 (116th)referred
United States · United States Congress · 27 June 2019
Emergency Access to Insulin Act of 2019 This bill reduces the marketing exclusivity period for biological drug products from 12 to 7 years and establishes policies and programs designed to increase access to prescription insulin. Specifically, the bill requires the Centers for Disease Control and Prevention to award grants to states to create insulin card programs, which provide uninsured or underinsured individuals with insulin at no cost for specified time periods. Payments for insulin prescriptions made through the program must count toward an underinsured individual’s health plan deductible. Further, the Department of Health and Human Services (HHS) must collect annual fees from insulin manufacturers, based on each manufacturer’s market share, equal to the total estimated expenditures under the insulin grants program. Subject to certain exceptions, the bill also establishes an excise tax on insulin manufacturers when the price of an insulin product spikes. The tax amount is a specified percentage of the revenue a manufacturer received as a result of the price spike. The tax amount increases in tiers based on the percentage of the price spike for that product.
Bill· SS. 2000 (116th)referred
United States · United States Congress · 27 June 2019
This bill makes permanent certain provisions regarding Medicaid eligibility that protect against spousal impoverishment for recipients of home and community-based services. Under current law, these provisions expire on September 30, 2019.
Bill· SS. 1999 (116th)referred
United States · United States Congress · 27 June 2019
Improving Low-Income Access to Prescription Drugs Act of 2019 This bill provides statutory authority for the Centers for Medicare & Medicaid Services transition program under the Medicare prescription drug benefit for limited-income, newly eligible individuals (i.e., individuals who are eligible for subsidies and have not yet enrolled in, or whose coverage has not yet taken effect under, a Medicare or Medicare Advantage prescription drug plan). The program's coverage provides immediate access to covered drugs at the point of sale as soon as the individual becomes eligible for subsidies; coverage also applies retroactively for dual eligible individuals and for individuals who receive benefits under the Supplemental Security Income program.
Bill· HRH.R. 3496 (116th)referred
United States · United States Congress · 26 June 2019
Community Re-Entry through Addiction Treatment to Enhance Opportunities Act or the CREATE Opportunities Act This bill establishes the Medication-Assisted Treatment Corrections and Community Reentry Program in the Department of Justice. Under the program, the National Institute of Corrections may award grants to support local programs that provide medication-assisted treatment for incarcerated individuals who have opioid-use disorder; such treatment must be provided in accordance with specified requirements, including drug, screening, and personnel criteria.
Bill· HRH.R. 3523 (116th)referred
United States · United States Congress · 26 June 2019
End Price Gouging for Medications Act This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including drug prices in listed countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.
Bill· HRH.R. 3520 (116th)referred
United States · United States Congress · 26 June 2019
Stem Cell Therapeutic and Research Reauthorization Act of 2019 This bill modifies and reauthorizes through FY2024 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also reauthorizes through FY2024 the Stem Cell Therapeutic and Research Act of 2005, which provides for the collection and maintenance of new units of high-quality cord blood. The bill requires the Advisory Council on Blood Stem Cell Transplantation to convene at least twice per calendar year.
Bill· HRH.R. 3502 (116th)referred
United States · United States Congress · 26 June 2019
Protecting People From Surprise Medical Bills Act This bill makes a series of changes relating to health care costs and billing practices. Among other things, the bill applies in-network cost-sharing requirements to certain emergency and related non-emergency services that are provided out-of-network; requires health insurers to include in-network and out-of-network deductibles, as well as out-of-pocket maximum limitations, on enrollee insurance cards; requires health insurers to provide online and print directories of in-network health care providers; and prohibits health care providers from billing individuals for services more than a year after such services are provided.
Bill· SS. 1997 (116th)referred
United States · United States Congress · 26 June 2019
Wildfire Smoke Relief Act This bill provides for assistance for the purchase of smoke inhalation prevention equipment to specified individuals at risk of wildfire smoke-related illness. The President, in carrying out the Transitional Sheltering Assistance Program of the Federal Emergency Management Agency (FEMA), shall provide (1) assistance to a state or local government, local public health authority, or a coordinated care organization to purchase and provide such equipment to at-risk individuals; and (2) cost-efficient transitional shelter assistance to at-risk individuals in any case in which such equipment is insufficient to mitigate the risk of illness.
Bill· SS. 1995 (116th)referred
United States · United States Congress · 26 June 2019
Safe Food Act of 2019 This bill establishes the Food Safety Administration (FSA) as an independent agency to administer and enforce food safety laws. The functions of specified federal agencies that relate to the administration or enforcement of food safety laws are transferred to the FSA. The FSA is directed to promulgate regulations to protect the food supply from contamination; implement federal food safety inspection, labeling, enforcement, and research efforts to protect the public health; develop consistent and science-based standards for safe food; prioritize federal food safety efforts and deployment of resources to achieve the greatest benefit in reducing foodborne illness; administer a national food safety program based on an analysis of the hazards associated with different foods and the processing of different foods; require that all food and feed facilities register before operation or importation of food, feed, or ingredients; establish an accreditation system for foreign governments seeking to certify food for importation to the United States; establish requirements for tracing food and animals from point of origin to retail sale; establish and administer a food safety technology program to foster innovations with the potential to improve food safety; maintain or access an active surveillance system of food and epidemiological evidence; establish a sampling system to monitor contaminants in food; rank categories of food based on their health hazard; establish a national public education campaign on food safety; and conduct research relating to food safety. This bill includes provisions regarding prohibited acts, recall authority, penalties for violations of food safety laws, whistle-blower protection, and civil actions.
Bill· SS. 1993 (116th)referred
United States · United States Congress · 26 June 2019
Patient Rights Act This bill prohibits the use of federal funds for health care services unless the entity receiving the funds certifies to the Department of Health and Human Services (HHS) that the entity respects all human life. Specifically, the entity must ensure that health care practitioners employed by or affiliated with the entity (1) exercise the same degree of professional skill and diligence to preserve the life and health of any patient as a conscientious health care practitioner would render to a patient in a different state of functionality, including patients in specified categories (e.g., terminally ill patients, elderly patients, and the unborn); (2) do not intentionally end the life of, or otherwise harm, any patient; and (3) do not institute a do-not-resuscitate or similar order without obtaining specified informed consent. In addition, HHS must (1) establish a public database that indicates whether an entity is in compliance, and (2) periodically review entities to ensure compliance. The Department of Justice or a person adversely affected may bring a civil action for violations.
Bill· SS. 1989 (116th)referred
United States · United States Congress · 26 June 2019
Provide Accurate Information Directly Act or PAID Act This bill requires the Centers for Medicare & Medicaid Services to identify, in response to an inquiry from certain non-group health plans (e.g., liability insurers), whether an individual was enrolled in Medicare, Medicare Advantage, or the Medicare prescription drug benefit during the preceding three-year period.
Bill· SS. 1987 (116th)referred
United States · United States Congress · 26 June 2019
End Price Gouging for Medications Act This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including drug prices in listed countries. Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.
Bill· SS. 1983 (116th)referred
United States · United States Congress · 26 June 2019
Community Re-Entry through Addiction Treatment to Enhance Opportunities Act or the CREATE Opportunities Act This bill establishes the Medication-Assisted Treatment Corrections and Community Reentry Program in the Department of Justice. Under the program, the National Institute of Corrections may award grants to support local programs that provide medication-assisted treatment for incarcerated individuals who have opioid-use disorders; such treatment must be provided in accordance with specified requirements, including drug, screening, and personnel criteria.
Bill· HRH.R. 3461 (116th)referred
United States · United States Congress · 25 June 2019
Community-Based Independence for Seniors Act of 2019 This bill establishes a Community-Based Institutional Special Needs Plan demonstration program through which up to five eligible Medicare Advantage (MA) organizations shall provide home and community-based care to eligible Medicare beneficiaries. For purposes of the demonstration program, an eligible Medicare beneficiary must be ineligible for Medicaid and unable to perform two or more activities of daily living. The Centers for Medicare & Medicaid Services (CMS) shall establish payment rates for eligible MA plans under the demonstration program. Such payment rates are capped but shall be in addition to payments otherwise made to MA organizations with respect to such plans. The CMS shall also (1) help to educate eligible Medicare beneficiaries on the availability of the program, and (2) provide for program evaluation by an independent third party.
PreviousPage 11 of 12Next